The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment (original) (raw)
- Experimental Oncology
- Published: 01 April 1993
British Journal of Cancer volume 67, pages 734–741 (1993)Cite this article
- 171 Accesses
- 46 Citations
- 3 Altmetric
- Metrics details
Abstract
Flunarizine is a class IV calcium channel blocker which increases oxygen delivery to hypoxic regions in solid tumours, exerting a radiosensitising effect in vivo in animal tumour models. Precisely how the drug improves oxygenation is not well understood. We hypothesised that metabolic conditions present within solid tumours reduce red blood cell (RBC) deformability and that flunarizine exerts its in vivo effect by preventing this loss of RBC deformability. A microrheometer was used to compare the viscosity of rat and human RBC suspensions in conditions of hypoxia (pO2 < 10 mmHg), acidic environment (pH 6.8), and elevated lactate concentration (lactate 5 mMol l-1), without or with flunarizine at concentrations of 5, 10, and 50 mg l-1. The effects of flunarizine on RBC density and morphology were also recorded. Hypoxia, low pH, and lactate exposure together increased both human and rat RBC suspension viscosity. Flunarizine at concentrations of 5 and 10 mg l-1 prevented the increases in viscosity. The drug caused dose-dependent shifts toward lower cell density while inducing a characteristic cupped shape (stomatcytic morphology), suggesting a mechanism involving calmodulin inhibition. The results support the hypothesis that flunarizine improves tumour blood flow and oxygenation by enhancing flow properties of RBC's in solid tumours.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Department of Radiation Oncology, Duke University Medical Center, Durham, 27710, NC
BD Kavanagh
Authors
- BD Kavanagh
- BE Coffey
- D Needham
- RM Hochmuth
- MW Dewhirst
Rights and permissions
About this article
Cite this article
Kavanagh, B., Coffey, B., Needham, D. et al. The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment.Br J Cancer 67, 734–741 (1993). https://doi.org/10.1038/bjc.1993.134
- Issue Date: 01 April 1993
- DOI: https://doi.org/10.1038/bjc.1993.134
This article is cited by
Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties
- Hayder M. Al-kuraishy
- Ali I. Al-Gareeb
- Gaber El-Saber Batiha
Clinical and Experimental Medicine (2022)
Transport of drugs from blood vessels to tumour tissue
- Mark W. Dewhirst
- Timothy W. Secomb
Nature Reviews Cancer (2017)
Decomposition of spontaneous fluctuations in tumour oxygenation using BOLD MRI and independent component analysis
- Miguel R Gonçalves
- S Peter Johnson
- Simon Walker-Samuel
British Journal of Cancer (2015)
Synthesis and biological activity of o-isobornylphenol derivatives
- M. B. Plotnikov
- V. I. Smol’yakova
- E. A. Krasnov
Pharmaceutical Chemistry Journal (2011)
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
- Mark W. Dewhirst
- Yiting Cao
- Benjamin Moeller
Nature Reviews Cancer (2008)